<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:hpo ids='HP_0001645'>Sudden cardiac death</z:hpo> (SCD) risk can be managed by implantable cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Defibrillation shocks can be delivered via <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> generator and/or intracardiac or subcutaneous coil configurations </plain></SENT>
<SENT sid="2" pm="."><plain>We present our single-centre use of childhood <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Twenty-three patients had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation, with median age and weight of 12.96 years and 41.35 kg </plain></SENT>
<SENT sid="4" pm="."><plain>Indications included eight long QT; four <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo>; three <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e>; two idiopathic <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo>; two post-congenital heart repair; two family history of SCD with abnormal repolarization; one catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>; and one left ventricle non-compaction </plain></SENT>
<SENT sid="5" pm="."><plain>Twelve had out of hospital <z:hpo ids='HP_0001695'>cardiac arrests</z:hpo> prior to implantation </plain></SENT>
<SENT sid="6" pm="."><plain>Techniques included 13 conventional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implants (pre-pectoral device with endocardial leads), 7 with subcutaneous defibrillation coils (sensing via epicardial or endocardial leads tunnelled to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>), and 3 with exclusive subcutaneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> (sensing and defibrillation via the same subcutaneous lead) </plain></SENT>
<SENT sid="7" pm="."><plain>Satisfactory defibrillation efficacy and <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> sensing was confirmed at implantation </plain></SENT>
<SENT sid="8" pm="."><plain>Follow-up ranged from 0.17 to 11.08 years </plain></SENT>
<SENT sid="9" pm="."><plain>One child died with the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> in situ </plain></SENT>
<SENT sid="10" pm="."><plain>Ten children received appropriate shocks; five on more than one occasion </plain></SENT>
<SENT sid="11" pm="."><plain>Five received inappropriate shocks (for inappropriate recognition of <z:hpo ids='HP_0011703'>sinus tachycardia</z:hpo> or <z:hpo ids='HP_0004755'>supraventricular tachycardia</z:hpo>) </plain></SENT>
<SENT sid="12" pm="."><plain>Five children underwent six further interventions; <z:hpo ids='HP_0000001'>all</z:hpo> had intracardiac leads </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: Innovative shock delivery systems can be used in children requiring an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>The insertion technique and device used need to accommodate the age and weight of the child, and concomitant need for pacing therapy </plain></SENT>
<SENT sid="15" pm="."><plain>We have demonstrated effective defibrillation with shocks delivered via configurations employing subcutaneous coils in children </plain></SENT>
</text></document>